Literature DB >> 11380438

Angiogenesis in multiple myeloma.

S V Rajkumar1, P R Greipp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11380438     DOI： 10.1046/j.1365-2141.2001.02690.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK.

Authors:  Yutaka Okawa; Teru Hideshima; Paul Steed; Sonia Vallet; Steven Hall; Ken Huang; John Rice; Amy Barabasz; Brianna Foley; Hiroshi Ikeda; Noopur Raje; Tanyel Kiziltepe; Hiroshi Yasui; Sotaro Enatsu; Kenneth C Anderson
Journal:  Blood       Date:  2008-10-23       Impact factor: 22.113

2.  Tumor angiogenesis as a target for dietary cancer prevention.

Authors:  William W Li; Vincent W Li; Michelle Hutnik; Albert S Chiou
Journal:  J Oncol       Date:  2011-09-29       Impact factor: 4.375

3.  Functional integration of acute myeloid leukemia into the vascular niche.

Authors:  Christopher R Cogle; Devorah C Goldman; Gerard J Madlambayan; Ronald P Leon; Azzah Al Masri; Hilary A Clark; Steven A Asbaghi; Jeffrey W Tyner; Jennifer Dunlap; Guang Fan; Tibor Kovacsovics; Qiuying Liu; Amy Meacham; Kimberly L Hamlin; Robert A Hromas; Edward W Scott; William H Fleming
Journal:  Leukemia       Date:  2014-03-18       Impact factor: 11.528
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.